FDARA, 21st Century Cures And The Era Of Perpetual FDA Reform
Executive Summary
The FDA Reauthorization Act will be remembered as the second half of a two-part legislative push – and, potentially, as the end of the notion that US FDA reforms are a once-every-five-year activity.
You may also be interested in...
US FDA Reforms In 2022: One Bill – Or Four?
The draft bipartisan user fee reauthorization bill includes more than 40 ride-along provisions to make changes at the US FDA. But there are at least three other bills moving in Congress that also make FDA reforms.
Waiting For Congress: Reforming, Paying For FDA OTC Monograph Program
FDA officials emphasize that without legislation from Congress, the OTC monograph program is not changing, and without a user fee program, the agency couldn’t implement changes.
Implementing User Fees Should Be Lighter Lift For FDA This Time Around; Bill Heads To White House
The 2017 user fee reauthorization bill contains provisions that should be significantly easier for the agency to implement compared with the 2012 measure. Senate clears clean bill for president's review.